Showing results (531-540 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|May 20, 2026
A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE TrialTakeshi Terashima, Masafumi Ikeda, Taro Yamashita, et al.
Liver Cancer|March 19, 2016
Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIIjin Joo, Jeong Min Lee
Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.
Liver Cancer|July 11, 2026
Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective StudyLin Ye, Guo-Xing Liu, Da-Long Yang, et al.
Liver Cancer|June 24, 2026
Comparison of Annual Dynamic Abbreviated MRI and Biannual Ultrasound for HCC Surveillance in a High-Risk Group: Two-Center Cohort StudyJeong Hee Yoon, Joon-Il Choi, Jeongin Yoo, et al.
Liver Cancer|June 24, 2026
Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular CarcinomaSae Yumita, Sadahisa Ogasawara, Makoto Fujiya, et al.
Liver Cancer|July 25, 2026
Hepatic Resection versus Stereotactic Body Radiation Therapy as Initial Local Treatment for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted AnalysisHye In Lee, Jinhong Jung, Gil-Chun Park, et al.
Liver Cancer|December 18, 2015
Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular CarcinomaDiana L Borgas, Jin-Song Gao, Ming Tong, et al.
Liver Cancer|July 29, 2026
Lenvatinib Added to Nivolumab and Ipilimumab Improves Tumor Control and Progression-Free Survival in Unresectable Hepatocellular CarcinomaKuan-Chang Lai, Chien-An Liu, Hao-Jan Lei, et al.
Liver Cancer|August 4, 2026
Acquired Genetic Variants, Not Tumor Mutation Burden, Drive Resistance to Immunotherapy in Hepatocellular CarcinomaJinho Lee, Hye Won Lee, Mi Ri Park, et al.
Pageof 55